NAAMECC backs conduct code

A new code ties disparate federal and state regulation, policy and other criteria into one document relevant to developing commercially supported CME.

A team of volunteers sifted through OIG, FDA, ACCME, PhRMA and other laws and standards, creating what they call “a broad view of best practices.”  The North American Association of Medical Education and Communication Companies (NAAMECC) endorsed the code, and it was distributed for other groups to consider at the recent AMA Task Force meeting. The 13-page Code of Conduct for Commercially Supported CME highlights relevant guidelines and standards in areas like conflicts of interest.
You must be a registered member of MMM to post a comment.
close

Next Article in Features

Email Newsletters


What does going "beyond the pill" actually mean? At MM&M's recent inaugural spring conference, audience members heard from real-world companies that are managing the organizational, technological, and promotional challenges inherent in this transition, such as partnering with health neophytes, harnessing technologies that allow deeper engagement with patients, and adopting a new commercial mindset to serve, not sell. Download here.


A wave of more effective anti-cancer drugs has set the oncology world on fire with enthusiasm. While many hail this as a new era, an equally vocal faction questions the money spent for the value gained. This medical and commercial trend report for marketers of anti-cancer modalities touches on many of the latest shifts that have expedited product launches and otherwise impacted promotion and reimbursement of these drugs. Click here.